1
|
Li J, Veeraraghavan P, Young SM. Ca V 2.1 α 1 subunit motifs that control presynaptic Ca V 2.1 subtype abundance are distinct from Ca V 2.1 preference. J Physiol 2024; 602:485-506. [PMID: 38155373 PMCID: PMC10872416 DOI: 10.1113/jp284957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Accepted: 11/30/2023] [Indexed: 12/30/2023] Open
Abstract
Presynaptic voltage-gated Ca2+ channel (CaV ) subtype abundance at mammalian synapses regulates synaptic transmission in health and disease. In the mammalian central nervous system (CNS), most presynaptic terminals are CaV 2.1 dominant with a developmental reduction in CaV 2.2 and CaV 2.3 levels, and CaV 2 subtype levels are altered in various diseases. However, the molecular mechanisms controlling presynaptic CaV 2 subtype levels are largely unsolved. Because the CaV 2 α1 subunit cytoplasmic regions contain varying levels of sequence conservation, these regions are proposed to control presynaptic CaV 2 subtype preference and abundance. To investigate the potential role of these regions, we expressed chimeric CaV 2.1 α1 subunits containing swapped motifs with the CaV 2.2 and CaV 2.3 α1 subunit on a CaV 2.1/CaV 2.2 null background at the calyx of Held presynaptic terminals. We found that expression of CaV 2.1 α1 subunit chimeras containing the CaV 2.3 loop II-III region or cytoplasmic C-terminus (CT) resulted in a large reduction of presynaptic Ca2+ currents compared to the CaV 2.1 α1 subunit. However, the Ca2+ current sensitivity to the CaV 2.1 blocker agatoxin-IVA was the same between the chimeras and the CaV 2.1 α1 subunit. Additionally, we found no reduction in presynaptic Ca2+ currents with CaV 2.1/2.2 cytoplasmic CT chimeras. We conclude that the motifs in the CaV 2.1 loop II-III and CT do not individually regulate CaV 2.1 preference, although these motifs control CaV 2.1 levels and the CaV 2.3 CT contains motifs that negatively regulate presynaptic CaV 2.3 levels. We propose that the motifs controlling presynaptic CaV 2.1 preference are distinct from those regulating CaV 2.1 levels and may act synergistically to impact pathways regulating CaV 2.1 preference and abundance. KEY POINTS: Presynaptic CaV 2 subtype abundance regulates neuronal circuit properties, although the mechanisms regulating presynaptic CaV 2 subtype abundance and preference remain enigmatic. The CaV α1 subunit determines subtype and contains multiple motifs implicated in regulating presynaptic subtype abundance and preference. The CaV 2.1 α1 subunit domain II-III loop and cytoplasmic C-terminus are positive regulators of presynaptic CaV 2.1 abundance but do not regulate preference. The CaV 2.3 α1 subunit cytoplasmic C-terminus negatively regulates presynaptic CaV 2 subtype abundance but not preference, whereas the CaV 2.2 α1 subunit cytoplasmic C-terminus is not a key regulator of presynaptic CaV 2 subtype abundance or preference. The CaV 2 α1 subunit motifs determining the presynaptic CaV 2 preference are distinct from abundance.
Collapse
Affiliation(s)
- Jianing Li
- Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA, USA
- Cell Developmental Biology Graduate Program, University of Iowa, Iowa City, IA 52242, USA
| | | | - Samuel M. Young
- Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA, USA
- Department of Otolaryngology, Iowa Neuroscience Institute, University of Iowa, Iowa City, IA, USA
| |
Collapse
|
2
|
Li J, Veeraraghavan P, Young SM. CaV2.1 α1 subunit motifs that control presynaptic CaV2.1 subtype abundance are distinct from CaV2.1 preference. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.04.28.538778. [PMID: 37162941 PMCID: PMC10168310 DOI: 10.1101/2023.04.28.538778] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
Presynaptic voltage-gated Ca2+ channels (CaV) subtype abundance at mammalian synapses regulates synaptic transmission in health and disease. In the mammalian central nervous system, most presynaptic terminals are CaV2.1 dominant with a developmental reduction in CaV2.2 and CaV2.3 levels, and CaV2 subtype levels are altered in various diseases. However, the molecular mechanisms controlling presynaptic CaV2 subtype levels are largely unsolved. Since the CaV2 α1 subunit cytoplasmic regions contain varying levels of sequence conservation, these regions are proposed to control presynaptic CaV2 subtype preference and abundance. To investigate the potential role of these regions, we expressed chimeric CaV2.1 α1subunits containing swapped motifs with the CaV2.2 and CaV2.3 α1 subunit on a CaV2.1/CaV2.2 null background at the calyx of Held presynaptic terminal. We found that expression of CaV2.1 α1 subunit chimeras containing the CaV2.3 loop II-III region or cytoplasmic C-terminus (CT) resulted in a large reduction of presynaptic Ca2+ currents compared to the CaV2.1 α1 subunit. However, the Ca2+ current sensitivity to the CaV2.1 blocker Agatoxin-IVA, was the same between the chimeras and the CaV2.1 α1 subunit. Additionally, we found no reduction in presynaptic Ca2+ currents with CaV2.1/2.2 cytoplasmic CT chimeras. We conclude that the motifs in the CaV2.1 loop II-III and CT do not individually regulate CaV2.1 preference, but these motifs control CaV2.1 levels and the CaV2.3 CT contains motifs that negatively regulate presynaptic CaV2.3 levels. We propose that the motifs controlling presynaptic CaV2.1 preference are distinct from those regulating CaV2.1 levels and may act synergistically to impact pathways regulating CaV2.1 preference and abundance.
Collapse
|
3
|
Knodel MM, Dutta Roy R, Wittum G. Influence of T-Bar on Calcium Concentration Impacting Release Probability. Front Comput Neurosci 2022; 16:855746. [PMID: 35586479 PMCID: PMC9108211 DOI: 10.3389/fncom.2022.855746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2022] [Accepted: 03/09/2022] [Indexed: 11/25/2022] Open
Abstract
The relation of form and function, namely the impact of the synaptic anatomy on calcium dynamics in the presynaptic bouton, is a major challenge of present (computational) neuroscience at a cellular level. The Drosophila larval neuromuscular junction (NMJ) is a simple model system, which allows studying basic effects in a rather simple way. This synapse harbors several special structures. In particular, in opposite to standard vertebrate synapses, the presynaptic boutons are rather large, and they have several presynaptic zones. In these zones, different types of anatomical structures are present. Some of the zones bear a so-called T-bar, a particular anatomical structure. The geometric form of the T-bar resembles the shape of the letter “T” or a table with one leg. When an action potential arises, calcium influx is triggered. The probability of vesicle docking and neurotransmitter release is superlinearly proportional to the concentration of calcium close to the vesicular release site. It is tempting to assume that the T-bar causes some sort of calcium accumulation and hence triggers a higher release probability and thus enhances neurotransmitter exocytosis. In order to study this influence in a quantitative manner, we constructed a typical T-bar geometry and compared the calcium concentration close to the active zones (AZs). We compared the case of synapses with and without T-bars. Indeed, we found a substantial influence of the T-bar structure on the presynaptic calcium concentrations close to the AZs, indicating that this anatomical structure increases vesicle release probability. Therefore, our study reveals how the T-bar zone implies a strong relation between form and function. Our study answers the question of experimental studies (namely “Wichmann and Sigrist, Journal of neurogenetics 2010”) concerning the sense of the anatomical structure of the T-bar.
Collapse
Affiliation(s)
- Markus M. Knodel
- Goethe Center for Scientific Computing (GCSC), Goethe Universität Frankfurt, Frankfurt, Germany
- *Correspondence: Markus M. Knodel ; orcid.org/0000-0001-8739-0803
| | | | - Gabriel Wittum
- Goethe Center for Scientific Computing (GCSC), Goethe Universität Frankfurt, Frankfurt, Germany
- Applied Mathematics and Computational Science, Computer, Electrical and Mathematical Science and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| |
Collapse
|
4
|
Paul MM, Dannhäuser S, Morris L, Mrestani A, Hübsch M, Gehring J, Hatzopoulos GN, Pauli M, Auger GM, Bornschein G, Scholz N, Ljaschenko D, Müller M, Sauer M, Schmidt H, Kittel RJ, DiAntonio A, Vakonakis I, Heckmann M, Langenhan T. The human cognition-enhancing CORD7 mutation increases active zone number and synaptic release. Brain 2022; 145:3787-3802. [DOI: 10.1093/brain/awac011] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 11/29/2021] [Accepted: 12/16/2021] [Indexed: 11/13/2022] Open
Abstract
Abstract
Humans carrying the CORD7 (cone-rod dystrophy 7) mutation possess increased verbal IQ and working memory. This autosomal dominant syndrome is caused by the single-amino acid R844H exchange (human numbering) located in the 310 helix of the C2A domain of RIMS1/RIM1 (Rab3-interacting molecule 1). RIM is an evolutionarily conserved multi-domain protein and essential component of presynaptic active zones, which is centrally involved in fast, Ca2+-triggered neurotransmitter release. How the CORD7 mutation affects synaptic function has remained unclear thus far. Here, we established Drosophila melanogaster as a disease model for clarifying the effects of the CORD7 mutation on RIM function and synaptic vesicle release.
To this end, using protein expression and X-ray crystallography, we solved the molecular structure of the Drosophila C2A domain at 1.92 Å resolution and by comparison to its mammalian homolog ascertained that the location of the CORD7 mutation is structurally conserved in fly RIM. Further, CRISPR/Cas9-assisted genomic engineering was employed for the generation of rim alleles encoding the R915H CORD7 exchange or R915E,R916E substitutions (fly numbering) to effect local charge reversal at the 310 helix. Through electrophysiological characterization by two-electrode voltage clamp and focal recordings we determined that the CORD7 mutation exerts a semi-dominant rather than a dominant effect on synaptic transmission resulting in faster, more efficient synaptic release and increased size of the readily releasable pool but decreased sensitivity for the fast calcium chelator BAPTA. In addition, the rim CORD7 allele increased the number of presynaptic active zones but left their nanoscopic organization unperturbed as revealed by super-resolution microscopy of the presynaptic scaffold protein Bruchpilot/ELKS/CAST.
We conclude that the CORD7 mutation leads to tighter release coupling, an increased readily releasable pool size and more release sites thereby promoting more efficient synaptic transmitter release. These results strongly suggest that similar mechanisms may underlie the CORD7 disease phenotype in patients and that enhanced synaptic transmission may contribute to their increased cognitive abilities.
Collapse
Affiliation(s)
- Mila M. Paul
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
- Department of Orthopaedic Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital of Würzburg, 97080 Würzburg, Germany
| | - Sven Dannhäuser
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
| | - Lydia Morris
- Division of General Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| | - Achmed Mrestani
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
- Division of General Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
- Department of Neurology, Leipzig University Medical Center, 04103 Leipzig, Germany
| | - Martha Hübsch
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
| | - Jennifer Gehring
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
| | | | - Martin Pauli
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
| | - Genevieve M. Auger
- Division of General Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| | - Grit Bornschein
- Carl Ludwig Institute of Physiology, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| | - Nicole Scholz
- Division of General Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| | - Dmitrij Ljaschenko
- Division of General Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| | - Martin Müller
- Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland
| | - Markus Sauer
- Department of Biotechnology and Biophysics, University of Würzburg, 97074 Würzburg, Germany
| | - Hartmut Schmidt
- Carl Ludwig Institute of Physiology, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| | - Robert J. Kittel
- Carl Ludwig Institute of Physiology, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
- Department of Animal Physiology, Institute of Biology, Leipzig University, 04103 Leipzig, Germany
| | - Aaron DiAntonio
- Department of Molecular Biology and Pharmacology, Washington University School of Medicine, Saint Louis, MO 63110, USA
| | | | - Manfred Heckmann
- Department of Neurophysiology, Institute of Physiology, University of Würzburg, 97070 Würzburg, Germany
| | - Tobias Langenhan
- Division of General Biochemistry, Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
| |
Collapse
|
5
|
Mohanraj N, Joshi NS, Poulose R, Patil RR, Santhoshkumar R, Kumar A, Waghmare GP, Saha AK, Haider SZ, Markandeya YS, Dey G, Rao LT, Govindaraj P, Mehta B. A proteomic study to unveil lead toxicity-induced memory impairments invoked by synaptic dysregulation. Toxicol Rep 2022; 9:1501-1513. [DOI: 10.1016/j.toxrep.2022.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 07/02/2022] [Accepted: 07/05/2022] [Indexed: 11/17/2022] Open
|
6
|
Bauché S, Sureau A, Sternberg D, Rendu J, Buon C, Messéant J, Boëx M, Furling D, Fauré J, Latypova X, Gelot AB, Mayer M, Mary P, Whalen S, Fournier E, Cloix I, Remerand G, Laffargue F, Nougues MC, Fontaine B, Eymard B, Isapof A, Strochlic L. New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes. NEUROLOGY-GENETICS 2020; 6:e534. [PMID: 33659639 PMCID: PMC7803339 DOI: 10.1212/nxg.0000000000000534] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Accepted: 09/25/2020] [Indexed: 11/15/2022]
Abstract
Objective To report the identification of 2 new homozygous recessive mutations in the synaptotagmin 2 (SYT2) gene as the genetic cause of severe and early presynaptic forms of congenital myasthenic syndromes (CMSs). Methods Next-generation sequencing identified new homozygous intronic and frameshift mutations in the SYT2 gene as a likely cause of presynaptic CMS. We describe the clinical and electromyographic patient phenotypes, perform ex vivo splicing analyses to characterize the effect of the intronic mutation on exon splicing, and analyze the functional impact of this variation at the neuromuscular junction (NMJ). Results The 2 infants presented a similar clinical phenotype evoking first a congenital myopathy characterized by muscle weakness and hypotonia. Next-generation sequencing allowed to the identification of 1 homozygous intronic mutation c.465+1G>A in patient 1 and another homozygous frameshift mutation c.328_331dup in patient 2, located respectively in the 5' splice donor site of SYT2 intron 4 and in exon 3. Functional studies of the intronic mutation validated the abolition of the splice donor site of exon 4 leading to its skipping. In-frame skipping of exon 4 that encodes part of the C2A calcium-binding domain of SYT2 is associated with a loss-of-function effect resulting in a decrease of neurotransmitter release and severe pre- and postsynaptic NMJ defects. Conclusions This study identifies new homozygous recessive SYT2 mutations as the underlying cause of severe and early presynaptic form of CMS expanding the genetic spectrum of recessive SYT2-related CMS associated with defects in neurotransmitter release.
Collapse
Affiliation(s)
- Stéphanie Bauché
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Alain Sureau
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Damien Sternberg
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - John Rendu
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Céline Buon
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Julien Messéant
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Myriam Boëx
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Denis Furling
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Julien Fauré
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Xénia Latypova
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Antoinette Bernabe Gelot
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Michèle Mayer
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Pierre Mary
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Sandra Whalen
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Emmanuel Fournier
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Isabelle Cloix
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Ganaelle Remerand
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Fanny Laffargue
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Marie-Christine Nougues
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Bertrand Fontaine
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Bruno Eymard
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Arnaud Isapof
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| | - Laure Strochlic
- Sorbonne Université, INSERM, UMRS974, Centre de Recherche en Myologie, Hôpital de la Pitié-Salpêtrière, Paris, (S.B., A.S., C. B., J.M., M.B., D.F., E. F., B.F., B.E., A.I., L.S.); CHU APHP (D.S., J.R., J.F., X.L., A.B.G., M.M., P.M., S.W., E.F., I.C., G.R., F.L., M.C.N., B.F., B.E., A.I.); Aix-Marseille University, INSERM, INMED, Campus de Luminy, Marseille, France (A.B.G.); UFR Cardiogénétique et Myogénétique, Hôpital de la Pitié-Salpêtrière, APHP, Paris (D.S.); UF de génétique clinique, CRMR Anomalies du développement et syndromes malformatifs, APHP, Hôpital Armand Trousseau, Paris, France (S.W.); Université de Grenoble Alpes, INSERM, CHU Grenoble Alpes, GIN (J.R., J.F., X.L.); CHU Clermont Ferrand (I.C., G.R., F.L.); and Reference Centre for Neuromuscular Pathologies "Nord/Est/Ile-de France" Paris (A.B.G., M.M., P.M., S.W., M.C.N., B.F., B.E., A.I.)
| |
Collapse
|
7
|
Guan Z, Quiñones-Frías MC, Akbergenova Y, Littleton JT. Drosophila Synaptotagmin 7 negatively regulates synaptic vesicle release and replenishment in a dosage-dependent manner. eLife 2020; 9:e55443. [PMID: 32343229 PMCID: PMC7224696 DOI: 10.7554/elife.55443] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Accepted: 04/28/2020] [Indexed: 01/03/2023] Open
Abstract
Synchronous neurotransmitter release is triggered by Ca2+ binding to the synaptic vesicle protein Synaptotagmin 1, while asynchronous fusion and short-term facilitation is hypothesized to be mediated by plasma membrane-localized Synaptotagmin 7 (SYT7). We generated mutations in Drosophila Syt7 to determine if it plays a conserved role as the Ca2+ sensor for these processes. Electrophysiology and quantal imaging revealed evoked release was elevated 2-fold. Syt7 mutants also had a larger pool of readily-releasable vesicles, faster recovery following stimulation, and intact facilitation. Syt1/Syt7 double mutants displayed more release than Syt1 mutants alone, indicating SYT7 does not mediate the residual asynchronous release remaining in the absence of SYT1. SYT7 localizes to an internal membrane tubular network within the peri-active zone, but does not enrich at active zones. These findings indicate the two Ca2+ sensor model of SYT1 and SYT7 mediating all phases of neurotransmitter release and facilitation is not applicable at Drosophila synapses.
Collapse
Affiliation(s)
- Zhuo Guan
- The Picower Institute for Learning and Memory, Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of TechnologyCambridgeUnited States
| | - Monica C Quiñones-Frías
- The Picower Institute for Learning and Memory, Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of TechnologyCambridgeUnited States
| | - Yulia Akbergenova
- The Picower Institute for Learning and Memory, Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of TechnologyCambridgeUnited States
| | - J Troy Littleton
- The Picower Institute for Learning and Memory, Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of TechnologyCambridgeUnited States
| |
Collapse
|
8
|
Fischl MJ, Ueberfuhr MA, Drexl M, Pagella S, Sinclair JL, Alexandrova O, Deussing JM, Kopp-Scheinpflug C. Urocortin 3 signalling in the auditory brainstem aids recovery of hearing after reversible noise-induced threshold shift. J Physiol 2019; 597:4341-4355. [PMID: 31270820 PMCID: PMC6852351 DOI: 10.1113/jp278132] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Accepted: 07/03/2019] [Indexed: 11/08/2022] Open
Abstract
KEY POINTS Ongoing, moderate noise exposure does not instantly damage the auditory system but may cause lasting deficits, such as elevated thresholds and accelerated ageing of the auditory system. The neuromodulatory peptide urocortin-3 (UCN3) is involved in the body's recovery from a stress response, and is also expressed in the cochlea and the auditory brainstem. Lack of UCN3 facilitates age-induced hearing loss and causes permanently elevated auditory thresholds following a single 2 h noise exposure at moderate intensities. Outer hair cell function in mice lacking UCN3 is unaffected, so that the observed auditory deficits are most likely due to inner hair cell function or central mechanisms. Highly specific, rather than ubiquitous, expression of UCN3 in the brain renders it a promising candidate for designing drugs to ameliorate stress-related auditory deficits, including recovery from acoustic trauma. ABSTRACT Environmental acoustic noise is omnipresent in our modern society, with sound levels that are considered non-damaging still causing long-lasting or permanent changes in the auditory system. The small neuromodulatory peptide urocortin-3 (UCN3) is the endogenous ligand for corticotropin-releasing factor receptor type 2 and together they are known to play an important role in stress recovery. UCN3 expression has been observed in the auditory brainstem, but its role remains unclear. Here we describe the detailed distribution of UCN3 expression in the murine auditory brainstem and provide evidence that UCN3 is expressed in the synaptic region of inner hair cells in the cochlea. We also show that mice with deficient UCN3 signalling experience premature ageing of the auditory system starting at an age of 4.7 months with significantly elevated thresholds of auditory brainstem responses (ABRs) compared to age-matched wild-type mice. Following a single, 2 h exposure to moderate (84 or 94 dB SPL) noise, UCN3-deficient mice exhibited significantly larger shifts in ABR thresholds combined with maladaptive recovery. In wild-type mice, the same noise exposure did not cause lasting changes to auditory thresholds. The presence of UCN3-expressing neurons throughout the auditory brainstem and the predisposition to hearing loss caused by preventing its normal expression suggests UCN3 as an important neuromodulatory peptide in the auditory system's response to loud sounds.
Collapse
Affiliation(s)
- Matthew J Fischl
- Department of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany
| | - Margarete A Ueberfuhr
- German Center for Vertigo and Balance Disorders, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany.,Graduate School of Systemic Neurosciences, Ludwig-Maximilians-University, Munich, Germany
| | - Markus Drexl
- German Center for Vertigo and Balance Disorders, University Hospital Munich, Ludwig-Maximilians-University, Munich, Germany
| | - Sara Pagella
- Department of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany.,Graduate School of Systemic Neurosciences, Ludwig-Maximilians-University, Munich, Germany
| | - James L Sinclair
- Department of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany
| | - Olga Alexandrova
- Department of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany
| | - Jan M Deussing
- Max Planck Institute of Psychiatry, Molecular Neurogenetics, Munich, Germany
| | - Conny Kopp-Scheinpflug
- Department of Biology II, Division Neurobiology, Ludwig-Maximilians-University, Munich, Germany
| |
Collapse
|
9
|
Abstract
Synaptotagmins (Syts) are well-established primary Ca2+ sensors to initiate presynaptic neurotransmitter release. They also play critical roles in the docking, priming, and fusion steps of exocytosis, as well as the tightly coupled exo-endocytosis, in presynapses. A recent study by Awasthi and others (2019) shows that Syt3 Ca2+-dependently modulates the postsynaptic receptor endocytosis and thereby promotes the long-term depression (LTD) and the decay of long-term potentiation (LTP). This work highlights the importance of Syt3 in modulating long-term synaptic plasticity and, importantly, extends the function of Syt proteins from presynaptic neurotransmitter release to a new promising postsynaptic receptor internalization.
Collapse
Affiliation(s)
- Xuanang Wu
- Center for Mitochondrial Biology and Medicine, the Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, China
| | - Shaoqin Hu
- Center for Mitochondrial Biology and Medicine, the Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, China
| | - Xinjiang Kang
- College of Life Sciences, Liaocheng University, Liaocheng, China.,Key Laboratory of Medical Electrophysiology, Ministry of Education of China, Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease, and the Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China
| | - Changhe Wang
- Center for Mitochondrial Biology and Medicine, the Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, China
| |
Collapse
|
10
|
Wrackmeyer U, Kaldrack J, Jüttner R, Pannasch U, Gimber N, Freiberg F, Purfürst B, Kainmueller D, Schmitz D, Haucke V, Rathjen FG, Gotthardt M. The cell adhesion protein CAR is a negative regulator of synaptic transmission. Sci Rep 2019; 9:6768. [PMID: 31043663 PMCID: PMC6494904 DOI: 10.1038/s41598-019-43150-5] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2018] [Accepted: 04/17/2019] [Indexed: 11/09/2022] Open
Abstract
The Coxsackievirus and adenovirus receptor (CAR) is essential for normal electrical conductance in the heart, but its role in the postnatal brain is largely unknown. Using brain specific CAR knockout mice (KO), we discovered an unexpected role of CAR in neuronal communication. This includes increased basic synaptic transmission at hippocampal Schaffer collaterals, resistance to fatigue, and enhanced long-term potentiation. Spontaneous neurotransmitter release and speed of endocytosis are increased in KOs, accompanied by increased expression of the exocytosis associated calcium sensor synaptotagmin 2. Using proximity proteomics and binding studies, we link CAR to the exocytosis machinery as it associates with syntenin and synaptobrevin/VAMP2 at the synapse. Increased synaptic function does not cause adverse effects in KO mice, as behavior and learning are unaffected. Thus, unlike the connexin-dependent suppression of atrioventricular conduction in the cardiac knockout, communication in the CAR deficient brain is improved, suggesting a role for CAR in presynaptic processes.
Collapse
Affiliation(s)
- Uta Wrackmeyer
- Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany
| | - Joanna Kaldrack
- Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany
| | - René Jüttner
- Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany.,Developmental Neurobiology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany
| | - Ulrike Pannasch
- Neuroscience Research Center, Cluster of Excellence NeuroCure, Charité, 10117, Berlin, Germany
| | - Niclas Gimber
- Department of Molecular Pharmacology and Cell Biology, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany
| | - Fabian Freiberg
- Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany
| | - Bettina Purfürst
- Core Facility Electron Microscopy, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany
| | - Dagmar Kainmueller
- Biomedical Image Analysis, Max Delbrück Center for Molecular Medicine and Berlin Institute of Health, 13125, Berlin, Germany
| | - Dietmar Schmitz
- Neuroscience Research Center, Cluster of Excellence NeuroCure, Charité, 10117, Berlin, Germany
| | - Volker Haucke
- Department of Molecular Pharmacology and Cell Biology, Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany
| | - Fritz G Rathjen
- Developmental Neurobiology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany
| | - Michael Gotthardt
- Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, 13125, Berlin, Germany.
| |
Collapse
|
11
|
Initial findings of striatum tripartite model in OCD brain samples based on transcriptome analysis. Sci Rep 2019; 9:3086. [PMID: 30816141 PMCID: PMC6395771 DOI: 10.1038/s41598-019-38965-1] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Accepted: 12/17/2018] [Indexed: 11/22/2022] Open
Abstract
Obsessive-compulsive disorder (OCD) is a psychiatric disorder characterized by obsessions and/or compulsions. Different striatal subregions belonging to the cortico-striato-thalamic circuitry (CSTC) play an important role in the pathophysiology of OCD. The transcriptomes of 3 separate striatal areas (putamen (PT), caudate nucleus (CN) and accumbens nucleus (NAC)) from postmortem brain tissue were compared between 6 OCD and 8 control cases. In addition to network connectivity deregulation, different biological processes are specific to each striatum region according to the tripartite model of the striatum and contribute in various ways to OCD pathophysiology. Specifically, regulation of neurotransmitter levels and presynaptic processes involved in chemical synaptic transmission were shared between NAC and PT. The Gene Ontology terms cellular response to chemical stimulus, response to external stimulus, response to organic substance, regulation of synaptic plasticity, and modulation of synaptic transmission were shared between CN and PT. Most genes harboring common and/or rare variants previously associated with OCD that were differentially expressed or part of a least preserved coexpression module in our study also suggest striatum subregion specificity. At the transcriptional level, our study supports differences in the 3 circuit CSTC model associated with OCD.
Collapse
|
12
|
Lübbert M, Goral RO, Keine C, Thomas C, Guerrero-Given D, Putzke T, Satterfield R, Kamasawa N, Young SM. Ca V2.1 α 1 Subunit Expression Regulates Presynaptic Ca V2.1 Abundance and Synaptic Strength at a Central Synapse. Neuron 2018; 101:260-273.e6. [PMID: 30545599 DOI: 10.1016/j.neuron.2018.11.028] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Revised: 10/22/2018] [Accepted: 11/15/2018] [Indexed: 11/28/2022]
Abstract
The abundance of presynaptic CaV2 voltage-gated Ca2+ channels (CaV2) at mammalian active zones (AZs) regulates the efficacy of synaptic transmission. It is proposed that presynaptic CaV2 levels are saturated in AZs due to a finite number of slots that set CaV2 subtype abundance and that CaV2.1 cannot compete for CaV2.2 slots. However, at most AZs, CaV2.1 levels are highest and CaV2.2 levels are developmentally reduced. To investigate CaV2.1 saturation states and preference in AZs, we overexpressed the CaV2.1 and CaV2.2 α1 subunits at the calyx of Held at immature and mature developmental stages. We found that AZs prefer CaV2.1 to CaV2.2. Remarkably, CaV2.1 α1 subunit overexpression drove increased CaV2.1 currents and channel numbers and increased synaptic strength at both developmental stages examined. Therefore, we propose that CaV2.1 levels in the AZ are not saturated and that synaptic strength can be modulated by increasing CaV2.1 levels to regulate neuronal circuit output. VIDEO ABSTRACT.
Collapse
Affiliation(s)
- Matthias Lübbert
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458, USA
| | - R Oliver Goral
- Department of Anatomy and Cell Biology, Iowa Neuroscience Institute, University of Iowa, Iowa City, IA 52242, USA
| | - Christian Keine
- Department of Anatomy and Cell Biology, Iowa Neuroscience Institute, University of Iowa, Iowa City, IA 52242, USA
| | - Connon Thomas
- Max Planck Florida Electron Microscopy Core, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458, USA
| | - Debbie Guerrero-Given
- Max Planck Florida Electron Microscopy Core, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458, USA
| | - Travis Putzke
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458, USA
| | - Rachel Satterfield
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458, USA
| | - Naomi Kamasawa
- Max Planck Florida Electron Microscopy Core, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458, USA
| | - Samuel M Young
- Department of Anatomy and Cell Biology, Iowa Neuroscience Institute, University of Iowa, Iowa City, IA 52242, USA; Department of Otolaryngology, Iowa Neuroscience Institute, Aging Mind Brain Initiative, University of Iowa, Iowa City, IA 52242, USA.
| |
Collapse
|
13
|
|
14
|
Durán E, Montes MÁ, Jemal I, Satterfield R, Young S, Álvarez de Toledo G. Synaptotagmin-7 controls the size of the reserve and resting pools of synaptic vesicles in hippocampal neurons. Cell Calcium 2018; 74:53-60. [PMID: 29957297 DOI: 10.1016/j.ceca.2018.06.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2018] [Revised: 06/04/2018] [Accepted: 06/18/2018] [Indexed: 02/07/2023]
Abstract
Continuous neurotransmitter release is subjected to synaptic vesicle availability, which in turn depends on vesicle recycling and the traffic of vesicles between pools. We studied the role of Synaptotagmin-7 (Syt-7) in synaptic vesicle accessibility for release in hippocampal neurons in culture. Synaptic boutons from Syt-7 knockout (KO) mice displayed normal basal secretion with no alteration in the RRP size or the probability of release. However, stronger stimuli revealed an increase in the size of the reserve and resting vesicle pools in Syt-7 KO boutons compared with WT. These data suggest that Syt-7 plays a significant role in the vesicle pool homeostasis and, consequently, in the availability of vesicles for synaptic transmission during strong stimulation, probably, by facilitating advancing synaptic vesicles to the readily releasable pool.
Collapse
Affiliation(s)
- Elisa Durán
- Dpto. Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain
| | - María Ángeles Montes
- Dpto. Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain
| | - Imane Jemal
- Dpto. Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain
| | - Rachel Satterfield
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute, Jupiter, FL 33458. USA
| | - Samuel Young
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute, Jupiter, FL 33458. USA
| | | |
Collapse
|
15
|
MacDougall DD, Lin Z, Chon NL, Jackman SL, Lin H, Knight JD, Anantharam A. The high-affinity calcium sensor synaptotagmin-7 serves multiple roles in regulated exocytosis. J Gen Physiol 2018; 150:783-807. [PMID: 29794152 PMCID: PMC5987875 DOI: 10.1085/jgp.201711944] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Accepted: 05/07/2018] [Indexed: 12/19/2022] Open
Abstract
MacDougall et al. review the structure and function of the calcium sensor synaptotagmin-7 in exocytosis. Synaptotagmin (Syt) proteins comprise a 17-member family, many of which trigger exocytosis in response to calcium. Historically, most studies have focused on the isoform Syt-1, which serves as the primary calcium sensor in synchronous neurotransmitter release. Recently, Syt-7 has become a topic of broad interest because of its extreme calcium sensitivity and diversity of roles in a wide range of cell types. Here, we review the known and emerging roles of Syt-7 in various contexts and stress the importance of its actions. Unique functions of Syt-7 are discussed in light of recent imaging, electrophysiological, and computational studies. Particular emphasis is placed on Syt-7–dependent regulation of synaptic transmission and neuroendocrine cell secretion. Finally, based on biochemical and structural data, we propose a mechanism to link Syt-7’s role in membrane fusion with its role in subsequent fusion pore expansion via strong calcium-dependent phospholipid binding.
Collapse
Affiliation(s)
| | - Zesen Lin
- Department of Pharmacology, University of Michigan, Ann Arbor, MI
| | - Nara L Chon
- Department of Chemistry, University of Colorado, Denver, CO
| | - Skyler L Jackman
- Vollum Institute, Oregon Health & Science University, Portland, OR
| | - Hai Lin
- Department of Chemistry, University of Colorado, Denver, CO
| | | | - Arun Anantharam
- Department of Pharmacology, University of Michigan, Ann Arbor, MI
| |
Collapse
|
16
|
Tejero R, Lopez-Manzaneda M, Arumugam S, Tabares L. Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. Hum Mol Genet 2018; 25:4703-4716. [PMID: 28173138 DOI: 10.1093/hmg/ddw297] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2016] [Revised: 08/22/2016] [Accepted: 08/23/2016] [Indexed: 01/19/2023] Open
Abstract
Spinal muscular atrophy (SMA) is the most frequent genetic cause of infant mortality. The disease is characterized by progressive muscle weakness and paralysis of axial and proximal limb muscles. It is caused by homozygous loss or mutation of the SMN1 gene, which codes for the Survival Motor Neuron (SMN) protein. In mouse models of the disease, neurotransmitter release is greatly impaired, but the molecular mechanisms of the synaptic dysfunction and the basis of the selective muscle vulnerability are unknown. In the present study, we investigated these open questions by comparing the molecular and functional properties of nerve terminals in severely and mildly affected muscles in the SMNΔ7 mouse model. We discovered that synaptotagmin-1 (Syt1) was developmentally downregulated in nerve terminals of highly affected muscles but not in low vulnerable muscles. Additionally, the expression levels of synaptotagmin-2 (Syt2), and its interacting protein, synaptic vesicle protein 2 (SV2) B, were reduced in proportion to the degree of muscle vulnerability while other synaptic proteins, such as syntaxin-1B (Stx1B) and synaptotagmin-7 (Syt7), were not affected. Consistently with the extremely low levels of both Syt-isoforms, and SV2B, in most affected neuromuscular synapses, the functional analysis of neurotransmission revealed highly reduced evoked release, altered short-term plasticity, low release probability, and inability to modulate normally the number of functional release sites. Together, we propose that the strong reduction of Syt2 and SV2B are key factors of the functional synaptic alteration and that the physiological downregulation of Syt1 plays a determinant role in muscle vulnerability in SMA.
Collapse
Affiliation(s)
- Rocío Tejero
- Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, Avda. Sánchez Pizjuán, 4. 41009 Seville, Spain
| | - Mario Lopez-Manzaneda
- Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, Avda. Sánchez Pizjuán, 4. 41009 Seville, Spain
| | - Saravanan Arumugam
- Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, Avda. Sánchez Pizjuán, 4. 41009 Seville, Spain
| | - Lucía Tabares
- Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, Avda. Sánchez Pizjuán, 4. 41009 Seville, Spain
| |
Collapse
|
17
|
SAKABA T. Kinetics of transmitter release at the calyx of Held synapse. PROCEEDINGS OF THE JAPAN ACADEMY. SERIES B, PHYSICAL AND BIOLOGICAL SCIENCES 2018; 94:139-152. [PMID: 29526973 PMCID: PMC5909059 DOI: 10.2183/pjab.94.010] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Accepted: 01/25/2018] [Indexed: 08/01/2023]
Abstract
Synaptic contacts mediate information transfer between neurons. The calyx of Held, a large synapse in the mammalian auditory brainstem, has been used as a model system for the mechanism of transmitter release from the presynaptic terminal for the last 20 years. By applying simultaneous recordings from pre- and postsynaptic compartments, the calcium-dependence of the kinetics of transmitter release has been quantified. A single pool of readily releasable vesicles cannot explain the time course of release during repetitive activity. Rather, multiple pools of vesicles have to be postulated that are replenished with distinct kinetics after depletion. The physical identity of vesicle replenishment has been unknown. Recently, it has become possible to apply total internal reflection fluorescent microscopy to the calyx terminal. This technique allowed the visualization of the dynamics of individual synaptic vesicles. Rather than recruitment of vesicles to the transmitter release sites, priming of tethered vesicles in the total internal reflection fluorescent field limited the number of readily releasable vesicles during sustained activity.
Collapse
Affiliation(s)
- Takeshi SAKABA
- Graduate School of Brain Science, Doshisha University, Kyoto, Japan
| |
Collapse
|
18
|
Chen C, Arai I, Satterfield R, Young SM, Jonas P. Synaptotagmin 2 Is the Fast Ca 2+ Sensor at a Central Inhibitory Synapse. Cell Rep 2017; 18:723-736. [PMID: 28099850 PMCID: PMC5276807 DOI: 10.1016/j.celrep.2016.12.067] [Citation(s) in RCA: 51] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2016] [Revised: 11/18/2016] [Accepted: 12/20/2016] [Indexed: 11/24/2022] Open
Abstract
GABAergic synapses in brain circuits generate inhibitory output signals with submillisecond latency and temporal precision. Whether the molecular identity of the release sensor contributes to these signaling properties remains unclear. Here, we examined the Ca2+ sensor of exocytosis at GABAergic basket cell (BC) to Purkinje cell (PC) synapses in cerebellum. Immunolabeling suggested that BC terminals selectively expressed synaptotagmin 2 (Syt2), whereas synaptotagmin 1 (Syt1) was enriched in excitatory terminals. Genetic elimination of Syt2 reduced action potential-evoked release to ∼10%, identifying Syt2 as the major Ca2+ sensor at BC-PC synapses. Differential adenovirus-mediated rescue revealed that Syt2 triggered release with shorter latency and higher temporal precision and mediated faster vesicle pool replenishment than Syt1. Furthermore, deletion of Syt2 severely reduced and delayed disynaptic inhibition following parallel fiber stimulation. Thus, the selective use of Syt2 as release sensor at BC-PC synapses ensures fast and efficient feedforward inhibition in cerebellar microcircuits. Syt2 is the Ca2+ sensor of fast transmitter release at a cerebellar GABAergic synapse Syt2 triggers transmitter release with faster time course than Syt1 Syt2 ensures faster replenishment of the readily releasable pool than Syt1 Syt2 is essential for fast feedforward inhibition in cerebellar microcircuits
Collapse
Affiliation(s)
- Chong Chen
- IST Austria (Institute of Science and Technology Austria), Am Campus 1, 3400 Klosterneuburg, Austria
| | - Itaru Arai
- IST Austria (Institute of Science and Technology Austria), Am Campus 1, 3400 Klosterneuburg, Austria
| | - Rachel Satterfield
- Max Planck Florida Institute for Neuroscience, Research Group Molecular Mechanisms of Synaptic Function, Jupiter, FL 33458, USA
| | - Samuel M Young
- Max Planck Florida Institute for Neuroscience, Research Group Molecular Mechanisms of Synaptic Function, Jupiter, FL 33458, USA
| | - Peter Jonas
- IST Austria (Institute of Science and Technology Austria), Am Campus 1, 3400 Klosterneuburg, Austria.
| |
Collapse
|
19
|
Synaptotagmin-1 drives synchronous Ca 2+-triggered fusion by C 2B-domain-mediated synaptic-vesicle-membrane attachment. Nat Neurosci 2017; 21:33-40. [PMID: 29230057 PMCID: PMC5742540 DOI: 10.1038/s41593-017-0037-5] [Citation(s) in RCA: 101] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2017] [Accepted: 10/14/2017] [Indexed: 12/19/2022]
Abstract
The synaptic vesicle (SV) protein Synaptotagmin-1 (Syt1) is the Ca2+ sensor for fast synchronous release. Biochemical and structural data suggest that Syt1 interacts with phospholipids and SNARE complex, but how these interactions translate into SV fusion remains poorly understood. Utilizing flash-and-freeze electron microscopy, which triggers action potentials (AP) with light and coordinately arrests synaptic structures with rapid freezing, we found synchronous release-impairing mutations in the Syt1 C2B domain (K325, 327; R398, 399) to also disrupt SV-active zone plasma membrane attachment. Single AP induction rescued membrane attachment in these mutants within <10ms through activation of the Syt1 Ca2+ binding site. The rapid SV membrane translocation temporarily correlates with resynchronization of release and paired pulse facilitation. Based on these findings, we redefine the role of Syt1 as part of Ca2+-dependent vesicle translocation machinery, and propose that Syt1 enables fast neurotransmitter release by means of its dynamic membrane attachment activities.
Collapse
|
20
|
Guan Z, Bykhovskaia M, Jorquera RA, Sutton RB, Akbergenova Y, Littleton JT. A synaptotagmin suppressor screen indicates SNARE binding controls the timing and Ca 2+ cooperativity of vesicle fusion. eLife 2017; 6:28409. [PMID: 28895532 PMCID: PMC5617632 DOI: 10.7554/elife.28409] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Accepted: 09/11/2017] [Indexed: 01/05/2023] Open
Abstract
The synaptic vesicle Ca2+ sensor Synaptotagmin binds Ca2+ through its two C2 domains to trigger membrane interactions. Beyond membrane insertion by the C2 domains, other requirements for Synaptotagmin activity are still being elucidated. To identify key residues within Synaptotagmin required for vesicle cycling, we took advantage of observations that mutations in the C2B domain Ca2+-binding pocket dominantly disrupt release from invertebrates to humans. We performed an intragenic screen for suppressors of lethality induced by expression of Synaptotagmin C2B Ca2+-binding mutants in Drosophila. This screen uncovered essential residues within Synaptotagmin that suggest a structural basis for several activities required for fusion, including a C2B surface implicated in SNARE complex interaction that is required for rapid synchronization and Ca2+ cooperativity of vesicle release. Using electrophysiological, morphological and computational characterization of these mutants, we propose a sequence of molecular interactions mediated by Synaptotagmin that promote Ca2+ activation of the synaptic vesicle fusion machinery.
Collapse
Affiliation(s)
- Zhuo Guan
- Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, United States.,Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.,Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, United States
| | - Maria Bykhovskaia
- Department of Neurology, School of Medicine, Wayne State University, Detroit, United States
| | - Ramon A Jorquera
- Neuroscience Department, Universidad Central del Caribe, Bayamon, Puerto Rico
| | - Roger Bryan Sutton
- Department of Cell Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, United States
| | - Yulia Akbergenova
- Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, United States.,Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.,Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, United States
| | - J Troy Littleton
- Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, United States.,Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.,Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, United States
| |
Collapse
|
21
|
Datta P, Gilliam J, Thoreson WB, Janz R, Heidelberger R. Two Pools of Vesicles Associated with Synaptic Ribbons Are Molecularly Prepared for Release. Biophys J 2017; 113:2281-2298. [PMID: 28863864 DOI: 10.1016/j.bpj.2017.08.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2017] [Revised: 07/28/2017] [Accepted: 08/07/2017] [Indexed: 11/17/2022] Open
Abstract
Neurons that form ribbon-style synapses are specialized for continuous exocytosis. To this end, their synaptic terminals contain numerous synaptic vesicles, some of which are ribbon associated, that have difference susceptibilities for undergoing Ca2+-dependent exocytosis. In this study, we probed the relationship between previously defined vesicle populations and determined their fusion competency with respect to SNARE complex formation. We found that both the rapidly releasing vesicle pool and the releasable vesicle pool of the retinal bipolar cell are situated at the ribbon-style active zones, where they functionally interact. A peptide inhibitor of SNARE complex formation failed to block exocytosis from either pool, suggesting that these two vesicle pools have formed the SNARE complexes necessary for fusion. By contrast, a third, slower component of exocytosis was blocked by the peptide, as was the functional replenishment of vesicle pools, indicating that few vesicles outside of the ribbon-style active zones were initially fusion competent. In cone photoreceptors, similar to bipolar cells, fusion of the initial ribbon-associated synaptic vesicle cohort was not blocked by the SNARE complex-inhibiting peptide, whereas a later phase of exocytosis, attributable to the recruitment and subsequent fusion of vesicles newly arrived at the synaptic ribbons, was blocked. Together, our results support a model in which stimulus-evoked exocytosis in retinal ribbon synapses is SNARE-dependent; where vesicles higher up on the synaptic ribbon replenish the rapidly releasing vesicle pool; and at any given time, there are sufficient SNARE complexes to support the fusion of the entire ribbon-associated cohort of vesicles. An important implication of these results is that ribbon-associated vesicles can form intervesicular SNARE complexes, providing mechanistic insight into compound fusion at ribbon-style synapses.
Collapse
Affiliation(s)
- Proleta Datta
- Department of Neurobiology and Anatomy, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, Texas
| | - Jared Gilliam
- Department of Neurobiology and Anatomy, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas
| | - Wallace B Thoreson
- Truhlsen Eye Institute, Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska
| | - Roger Janz
- Department of Neurobiology and Anatomy, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, Texas
| | - Ruth Heidelberger
- Department of Neurobiology and Anatomy, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
| |
Collapse
|
22
|
Lübbert M, Goral RO, Satterfield R, Putzke T, van den Maagdenberg AM, Kamasawa N, Young SM. A novel region in the Ca V2.1 α 1 subunit C-terminus regulates fast synaptic vesicle fusion and vesicle docking at the mammalian presynaptic active zone. eLife 2017; 6. [PMID: 28786379 PMCID: PMC5548488 DOI: 10.7554/elife.28412] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2017] [Accepted: 07/06/2017] [Indexed: 01/23/2023] Open
Abstract
In central nervous system (CNS) synapses, action potential-evoked neurotransmitter release is principally mediated by CaV2.1 calcium channels (CaV2.1) and is highly dependent on the physical distance between CaV2.1 and synaptic vesicles (coupling). Although various active zone proteins are proposed to control coupling and abundance of CaV2.1 through direct interactions with the CaV2.1 α1 subunit C-terminus at the active zone, the role of these interaction partners is controversial. To define the intrinsic motifs that regulate coupling, we expressed mutant CaV2.1 α1 subunits on a CaV2.1 null background at the calyx of Held presynaptic terminal. Our results identified a region that directly controlled fast synaptic vesicle release and vesicle docking at the active zone independent of CaV2.1 abundance. In addition, proposed individual direct interactions with active zone proteins are insufficient for CaV2.1 abundance and coupling. Therefore, our work advances our molecular understanding of CaV2.1 regulation of neurotransmitter release in mammalian CNS synapses.
Collapse
Affiliation(s)
- Matthias Lübbert
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, United States
| | - R Oliver Goral
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, United States.,Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States
| | - Rachel Satterfield
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, United States
| | - Travis Putzke
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, United States
| | | | - Naomi Kamasawa
- Max Planck Florida Electron Microscopy Core, Max Planck Florida Institute for Neuroscience, Jupiter, United States
| | - Samuel M Young
- Research Group Molecular Mechanisms of Synaptic Function, Max Planck Florida Institute for Neuroscience, Jupiter, United States.,Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States.,Department of Otolaryngology, University of Iowa, Iowa City, United States.,Iowa Neuroscience Institute, University of Iowa, Iowa City, United States.,Aging Mind Brain Initiative, University of Iowa, Iowa City, United States
| |
Collapse
|
23
|
Pinheiro PS, Houy S, Sørensen JB. C2-domain containing calcium sensors in neuroendocrine secretion. J Neurochem 2016; 139:943-958. [DOI: 10.1111/jnc.13865] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Revised: 09/17/2016] [Accepted: 10/05/2016] [Indexed: 12/11/2022]
Affiliation(s)
- Paulo S. Pinheiro
- Center for Neuroscience and Cell Biology; University of Coimbra; Coimbra Portugal
| | - Sébastien Houy
- Department of Neuroscience and Pharmacology; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark
| | - Jakob B. Sørensen
- Department of Neuroscience and Pharmacology; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark
| |
Collapse
|
24
|
Böhme MA, Beis C, Reddy-Alla S, Reynolds E, Mampell MM, Grasskamp AT, Lützkendorf J, Bergeron DD, Driller JH, Babikir H, Göttfert F, Robinson IM, O'Kane CJ, Hell SW, Wahl MC, Stelzl U, Loll B, Walter AM, Sigrist SJ. Active zone scaffolds differentially accumulate Unc13 isoforms to tune Ca2+ channel–vesicle coupling. Nat Neurosci 2016; 19:1311-20. [DOI: 10.1038/nn.4364] [Citation(s) in RCA: 136] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Accepted: 07/20/2016] [Indexed: 01/05/2023]
|
25
|
Reconstitution of Giant Mammalian Synapses in Culture for Molecular Functional and Imaging Studies. J Neurosci 2016; 36:3600-10. [PMID: 27013688 DOI: 10.1523/jneurosci.3869-15.2016] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2015] [Accepted: 02/22/2016] [Indexed: 11/21/2022] Open
Abstract
UNLABELLED Giant presynaptic terminal brain slice preparations have allowed intracellular recording of electrical signals and molecular loading, elucidating cellular and molecular mechanisms underlying neurotransmission and modulation. However, molecular genetic manipulation or optical imaging in these preparations is hampered by factors, such as tissue longevity and background fluorescence. To overcome these difficulties, we developed a giant presynaptic terminal culture preparation, which allows genetic manipulation and enables optical measurements of synaptic vesicle dynamics, simultaneously with presynaptic electrical signal recordings. This giant synapse reconstructed from dissociated mouse brainstem neurons resembles the development of native calyceal giant synapses in several respects. Thus, this novel preparation constitutes a powerful tool for studying molecular mechanisms of neurotransmission, neuromodulation, and neuronal development. SIGNIFICANCE STATEMENT We have developed a novel culture preparation of giant mammalian synapses. These presynaptic terminals make it possible to perform optical imaging simultaneously with presynaptic electrophysiological recording. We demonstrate that this enables one to dissect endocytic and acidification times of synaptic vesicles. In addition, developmental elimination and functional maturation in this cultured preparation provide a useful model for studying presynaptic development. Because this giant synapse preparation allows molecular genetic manipulations, it constitutes a powerful new tool for studying molecular mechanisms of neurotransmission, neuromodulation, and neuronal development.
Collapse
|
26
|
Kochubey O, Babai N, Schneggenburger R. A Synaptotagmin Isoform Switch during the Development of an Identified CNS Synapse. Neuron 2016; 90:984-99. [DOI: 10.1016/j.neuron.2016.04.038] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Revised: 02/26/2016] [Accepted: 04/20/2016] [Indexed: 01/08/2023]
|
27
|
Cárdenas AM, Marengo FD. How the stimulus defines the dynamics of vesicle pool recruitment, fusion mode, and vesicle recycling in neuroendocrine cells. J Neurochem 2016; 137:867-79. [DOI: 10.1111/jnc.13565] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2015] [Revised: 01/05/2016] [Accepted: 01/25/2016] [Indexed: 01/08/2023]
Affiliation(s)
- Ana María Cárdenas
- Centro Interdisciplinario de Neurociencia de Valparaíso; Universidad de Valparaíso; Valparaíso Chile
| | - Fernando D. Marengo
- Laboratorio de Fisiología y Biología Molecular; Instituto de Fisiología; Biología Molecular y Neurociencias (CONICET); Departamento de Fisiología y Biología Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires Argentina
| |
Collapse
|
28
|
Kittel RJ, Heckmann M. Synaptic Vesicle Proteins and Active Zone Plasticity. Front Synaptic Neurosci 2016; 8:8. [PMID: 27148040 PMCID: PMC4834300 DOI: 10.3389/fnsyn.2016.00008] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2016] [Accepted: 03/31/2016] [Indexed: 11/13/2022] Open
Abstract
Neurotransmitter is released from synaptic vesicles at the highly specialized presynaptic active zone (AZ). The complex molecular architecture of AZs mediates the speed, precision and plasticity of synaptic transmission. Importantly, structural and functional properties of AZs vary significantly, even for a given connection. Thus, there appear to be distinct AZ states, which fundamentally influence neuronal communication by controlling the positioning and release of synaptic vesicles. Vice versa, recent evidence has revealed that synaptic vesicle components also modulate organizational states of the AZ. The protein-rich cytomatrix at the active zone (CAZ) provides a structural platform for molecular interactions guiding vesicle exocytosis. Studies in Drosophila have now demonstrated that the vesicle proteins Synaptotagmin-1 (Syt1) and Rab3 also regulate glutamate release by shaping differentiation of the CAZ ultrastructure. We review these unexpected findings and discuss mechanistic interpretations of the reciprocal relationship between synaptic vesicles and AZ states, which has heretofore received little attention.
Collapse
Affiliation(s)
- Robert J Kittel
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| | - Manfred Heckmann
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| |
Collapse
|
29
|
Körber C, Kuner T. Molecular Machines Regulating the Release Probability of Synaptic Vesicles at the Active Zone. Front Synaptic Neurosci 2016; 8:5. [PMID: 26973506 PMCID: PMC4773589 DOI: 10.3389/fnsyn.2016.00005] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2015] [Accepted: 02/17/2016] [Indexed: 11/13/2022] Open
Abstract
The fusion of synaptic vesicles (SVs) with the plasma membrane of the active zone (AZ) upon arrival of an action potential (AP) at the presynaptic compartment is a tightly regulated probabilistic process crucial for information transfer. The probability of a SV to release its transmitter content in response to an AP, termed release probability (Pr), is highly diverse both at the level of entire synapses and individual SVs at a given synapse. Differences in Pr exist between different types of synapses, between synapses of the same type, synapses originating from the same axon and even between different SV subpopulations within the same presynaptic terminal. The Pr of SVs at the AZ is set by a complex interplay of different presynaptic properties including the availability of release-ready SVs, the location of the SVs relative to the voltage-gated calcium channels (VGCCs) at the AZ, the magnitude of calcium influx upon arrival of the AP, the buffering of calcium ions as well as the identity and sensitivity of the calcium sensor. These properties are not only interconnected, but can also be regulated dynamically to match the requirements of activity patterns mediated by the synapse. Here, we review recent advances in identifying molecules and molecular machines taking part in the determination of vesicular Pr at the AZ.
Collapse
Affiliation(s)
- Christoph Körber
- Department of Functional Neuroanatomy, Institute of Anatomy and Cell Biology, Heidelberg University Heidelberg, Germany
| | - Thomas Kuner
- Department of Functional Neuroanatomy, Institute of Anatomy and Cell Biology, Heidelberg University Heidelberg, Germany
| |
Collapse
|
30
|
A Post-Docking Role of Synaptotagmin 1-C2B Domain Bottom Residues R398/399 in Mouse Chromaffin Cells. J Neurosci 2016; 35:14172-82. [PMID: 26490858 DOI: 10.1523/jneurosci.1911-15.2015] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
UNLABELLED Synaptotagmin-1 (Syt1) is the principal Ca(2+) sensor for vesicle fusion and is also essential for vesicle docking in chromaffin cells. Docking depends on interactions of the Syt1-C2B domain with the t-SNARE SNAP25/Syntaxin1 complex and/or plasma membrane phospholipids. Here, we investigated the role of the positively charged "bottom" region of the C2B domain, proposed to help crosslink membranes, in vesicle docking and secretion in mouse chromaffin cells and in cell-free assays. We expressed a double mutation shown previously to interfere with lipid mixing between proteoliposomes and with synaptic transmission, Syt1-R398/399Q (RQ), in syt1 null mutant cells. Ultrastructural morphometry revealed that Syt1-RQ fully restored the docking defect observed previously in syt1 null mutant cells, similar to wild type Syt1 (Syt1-wt). Small unilamellar lipid vesicles (SUVs) that contained the v-SNARE Synaptobrevin2 and Syt1-R398/399Q also docked to t-SNARE-containing giant vesicles (GUVs), similar to Syt1-wt. However, unlike Syt1-wt, Syt1-RQ-induced docking was strictly PI(4,5)P2-dependent. Unlike docking, neither synchronized secretion in chromaffin cells nor Ca(2+)-triggered SUV-GUV fusion was restored by the Syt1 mutants. Finally, overexpressing the RQ-mutant in wild type cells produced no effect on either docking or secretion. We conclude that the positively charged bottom region in the C2B domain--and, by inference, Syt1-mediated membrane crosslinking--is required for triggering fusion, but not for docking. Secretory vesicles dock by multiple, PI(4,5)P2-dependent and PI(4,5)P2-independent mechanisms. The R398/399 mutations selectively disrupt the latter and hereby help to discriminate protein regions involved in different aspects of Syt1 function in docking and fusion. SIGNIFICANCE STATEMENT This study provides new insights in how the two opposite sides of the C2B domain of Synaptotagmin-1 participate in secretory vesicle fusion, and in more upstream steps, especially vesicle docking. We show that the "bottom" surface of the C2B domain is required for triggering fusion, but not for docking. Synaptotagmin-1 promotes docking by multiple, PI(4,5)P2-dependent and PI(4,5)P2-independent mechanisms. Mutations in the C2B bottom surface (R398/399) selectively disrupt the latter. These mutations help to discriminate protein regions involved in different aspects of Synaptotagmin-1 function in docking and fusion.
Collapse
|
31
|
Abstract
UNLABELLED The Ca(2+) sensor synaptotagmin-1 (syt-1) regulates neurotransmitter release by interacting with anionic phospholipids. Here we test the idea that the intrinsic kinetics of syt-membrane interactions determine, in part, the time course of synaptic transmission. To tune the kinetics of this interaction, we grafted structural elements from the slowest isoform, syt-7, onto the fastest isoform, syt-1, resulting in a chimera with intermediate kinetic properties. Moreover, the chimera coupled a physiologically irrelevant metal, Sr(2+), to membrane fusion in vitro. When substituted for syt-1 in mouse hippocampal neurons, the chimera slowed the kinetics of synaptic transmission. Neurons expressing the chimera also evinced rapid and efficient Sr(2+) triggered release, in contrast to the weak response of neurons expressing syt-1. These findings reveal presynaptic sensor-membrane interactions as a major factor regulating the speed of the release machinery. Finally, the chimera failed to clamp the elevated spontaneous fusion rate exhibited by syt-1 KO neurons, indicating that the metal binding loops of syt-1 regulate the two modes of release by distinct mechanisms. SIGNIFICANCE STATEMENT In calcium, synaptotagmin-1 triggers neurotransmitter release by interacting with membranes. Here, we demonstrate that intrinsic properties of this interaction control the time course of synaptic transmission. We engineered a "chimera" using synaptotagmin-1 and elements of a slower isoform, synaptotagmin-7. When expressed in neurons, the chimera slowed the rate of neurotransmitter release. Furthermore, unlike native synaptotagmin-1, the chimera was able to function robustly in the presence of strontium-a metal not present in cells. We exploited this ability to show that a key function of synaptotagmin-1 is to penetrate cell membranes. This work sheds light on fundamental mechanisms of neurotransmitter release.
Collapse
|
32
|
Whittaker RG, Herrmann DN, Bansagi B, Hasan BAS, Lofra RM, Logigian EL, Sowden JE, Almodovar JL, Littleton JT, Zuchner S, Horvath R, Lochmüller H. Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome. Neurology 2015; 85:1964-71. [PMID: 26519543 DOI: 10.1212/wnl.0000000000002185] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2015] [Accepted: 08/06/2015] [Indexed: 01/27/2023] Open
Abstract
OBJECTIVES To describe the clinical and electrophysiologic features of synaptotagmin II (SYT2) mutations, a novel neuromuscular syndrome characterized by foot deformities and fatigable ocular and lower limb weakness, and the response to modulators of acetylcholine release. METHODS We performed detailed clinical and neurophysiologic assessment in 2 multigenerational families with dominant SYT2 mutations (c.920T>G [p.Asp307Ala] and c.923G>A [p.Pro308Leu]). Serial clinical and electrophysiologic assessments were performed in members of one family treated first with pyridostigmine and then with 3,4-diaminopyridine. RESULTS Electrophysiologic testing revealed features indicative of a presynaptic deficit in neurotransmitter release with posttetanic potentiation lasting up to 60 minutes. Treatment with 3,4-diaminopyridine produced both a clinical benefit and an improvement in neuromuscular transmission. CONCLUSION SYT2 mutations cause a novel and potentially treatable complex presynaptic congenital myasthenic syndrome characterized by motor neuropathy causing lower limb wasting and foot deformities, with reflex potentiation following exercise and a uniquely prolonged period of posttetanic potentiation.
Collapse
Affiliation(s)
- Roger G Whittaker
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL.
| | - David N Herrmann
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Boglarka Bansagi
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Bashar Awwad Shiekh Hasan
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Robert Muni Lofra
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Eric L Logigian
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Janet E Sowden
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Jorge L Almodovar
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - J Troy Littleton
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Stephan Zuchner
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Rita Horvath
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| | - Hanns Lochmüller
- From the Institute of Neuroscience (R.G.W., B.A.S.H.) and John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine (B.B., R.M.L., R.H., H.L.), Newcastle University, Newcastle, UK; Department of Neurology (D.N.H., E.L.L., J.E.S.), University of Rochester Medical Center, NY; Department of Neurology (J.L.A.), Dartmouth Hitchcock Clinic, Geisel School of Medicine, Hanover, NH; The Picower Institute for Learning and Memory (J.T.L.), Department of Biology and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA; and Dr. John T. Macdonald Department of Human Genetics and Hussman Institute for Human Genomics (S.Z.), University of Miami, Miller School of Medicine, Miami, FL
| |
Collapse
|
33
|
Bacaj T, Wu D, Burré J, Malenka RC, Liu X, Südhof TC. Synaptotagmin-1 and -7 Are Redundantly Essential for Maintaining the Capacity of the Readily-Releasable Pool of Synaptic Vesicles. PLoS Biol 2015; 13:e1002267. [PMID: 26437117 PMCID: PMC4593569 DOI: 10.1371/journal.pbio.1002267] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2015] [Accepted: 08/27/2015] [Indexed: 12/29/2022] Open
Abstract
In forebrain neurons, Ca(2+) triggers exocytosis of readily releasable vesicles by binding to synaptotagmin-1 and -7, thereby inducing fast and slow vesicle exocytosis, respectively. Loss-of-function of synaptotagmin-1 or -7 selectively impairs the fast and slow phase of release, respectively, but does not change the size of the readily-releasable pool (RRP) of vesicles as measured by stimulation of release with hypertonic sucrose, or alter the rate of vesicle priming into the RRP. Here we show, however, that simultaneous loss-of-function of both synaptotagmin-1 and -7 dramatically decreased the capacity of the RRP, again without altering the rate of vesicle priming into the RRP. Either synaptotagmin-1 or -7 was sufficient to rescue the RRP size in neurons lacking both synaptotagmin-1 and -7. Although maintenance of RRP size was Ca(2+)-independent, mutations in Ca(2+)-binding sequences of synaptotagmin-1 or synaptotagmin-7--which are contained in flexible top-loop sequences of their C2 domains--blocked the ability of these synaptotagmins to maintain the RRP size. Both synaptotagmins bound to SNARE complexes; SNARE complex binding was reduced by the top-loop mutations that impaired RRP maintenance. Thus, synaptotagmin-1 and -7 perform redundant functions in maintaining the capacity of the RRP in addition to nonredundant functions in the Ca(2+) triggering of different phases of release.
Collapse
Affiliation(s)
- Taulant Bacaj
- Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University, Stanford, California, United States of America
| | - Dick Wu
- Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University, Stanford, California, United States of America
- Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, Stanford, California, United States of America
| | - Jacqueline Burré
- Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University, Stanford, California, United States of America
| | - Robert C. Malenka
- Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University Medical School, Stanford, California, United States of America
| | - Xinran Liu
- Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, United States of America
| | - Thomas C. Südhof
- Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University, Stanford, California, United States of America
- * E-mail:
| |
Collapse
|
34
|
Zhou Q, Lai Y, Bacaj T, Zhao M, Lyubimov AY, Uervirojnangkoorn M, Zeldin OB, Brewster AS, Sauter NK, Cohen AE, Soltis SM, Alonso-Mori R, Chollet M, Lemke HT, Pfuetzner RA, Choi UB, Weis WI, Diao J, Südhof TC, Brunger AT. Architecture of the synaptotagmin-SNARE machinery for neuronal exocytosis. Nature 2015; 525:62-7. [PMID: 26280336 PMCID: PMC4607316 DOI: 10.1038/nature14975] [Citation(s) in RCA: 219] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 07/27/2015] [Indexed: 02/07/2023]
Abstract
Synaptotagmin-1 and neuronal SNARE proteins have central roles in evoked synchronous neurotransmitter release; however, it is unknown how they cooperate to trigger synaptic vesicle fusion. Here we report atomic-resolution crystal structures of Ca(2+)- and Mg(2+)-bound complexes between synaptotagmin-1 and the neuronal SNARE complex, one of which was determined with diffraction data from an X-ray free-electron laser, leading to an atomic-resolution structure with accurate rotamer assignments for many side chains. The structures reveal several interfaces, including a large, specific, Ca(2+)-independent and conserved interface. Tests of this interface by mutagenesis suggest that it is essential for Ca(2+)-triggered neurotransmitter release in mouse hippocampal neuronal synapses and for Ca(2+)-triggered vesicle fusion in a reconstituted system. We propose that this interface forms before Ca(2+) triggering, moves en bloc as Ca(2+) influx promotes the interactions between synaptotagmin-1 and the plasma membrane, and consequently remodels the membrane to promote fusion, possibly in conjunction with other interfaces.
Collapse
Affiliation(s)
- Qiangjun Zhou
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Ying Lai
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Taulant Bacaj
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
| | - Minglei Zhao
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Artem Y Lyubimov
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Monarin Uervirojnangkoorn
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Oliver B Zeldin
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Aaron S Brewster
- Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Nicholas K Sauter
- Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Aina E Cohen
- SLAC National Accelerator Laboratory, Stanford, California 94305, USA
| | - S Michael Soltis
- SLAC National Accelerator Laboratory, Stanford, California 94305, USA
| | | | - Matthieu Chollet
- SLAC National Accelerator Laboratory, Stanford, California 94305, USA
| | - Henrik T Lemke
- SLAC National Accelerator Laboratory, Stanford, California 94305, USA
| | - Richard A Pfuetzner
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Ucheor B Choi
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - William I Weis
- Departments of Structural Biology, Molecular and Cellular Physiology, and Photon Science, Stanford University, Stanford, California 94305, USA
| | - Jiajie Diao
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| | - Thomas C Südhof
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
| | - Axel T Brunger
- Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, USA
- Departments of Neurology and Neurological Sciences, Photon Science, and Structural Biology, Stanford University, Stanford, California 94305, USA
| |
Collapse
|
35
|
Complexin stabilizes newly primed synaptic vesicles and prevents their premature fusion at the mouse calyx of held synapse. J Neurosci 2015; 35:8272-90. [PMID: 26019341 DOI: 10.1523/jneurosci.4841-14.2015] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Complexins (Cplxs) are small synaptic proteins that cooperate with SNARE-complexes in the control of synaptic vesicle (SV) fusion. Studies involving genetic mutation, knock-down, or knock-out indicated two key functions of Cplx that are not mutually exclusive but cannot easily be reconciled, one in facilitating SV fusion, and one in "clamping" SVs to prevent premature fusion. Most studies on the role of Cplxs in mammalian synapse function have relied on cultured neurons, heterologous expression systems, or membrane fusion assays in vitro, whereas little is known about the function of Cplxs in native synapses. We therefore studied consequences of genetic ablation of Cplx1 in the mouse calyx of Held synapse, and discovered a developmentally exacerbating phenotype of reduced spontaneous and evoked transmission but excessive asynchronous release after stimulation, compatible with combined facilitating and clamping functions of Cplx1. Because action potential waveforms, Ca(2+) influx, readily releasable SV pool size, and quantal size were unaltered, the reduced synaptic strength in the absence of Cplx1 is most likely a consequence of a decreased release probability, which is caused, in part, by less tight coupling between Ca(2+) channels and docked SV. We found further that the excessive asynchronous release in Cplx1-deficient calyces triggered aberrant action potentials in their target neurons, and slowed-down the recovery of EPSCs after depleting stimuli. The augmented asynchronous release had a delayed onset and lasted hundreds of milliseconds, indicating that it predominantly represents fusion of newly recruited SVs, which remain unstable and prone to premature fusion in the absence of Cplx1.
Collapse
|
36
|
Körber C, Horstmann H, Venkataramani V, Herrmannsdörfer F, Kremer T, Kaiser M, Schwenger DB, Ahmed S, Dean C, Dresbach T, Kuner T. Modulation of Presynaptic Release Probability by the Vertebrate-Specific Protein Mover. Neuron 2015. [PMID: 26212709 DOI: 10.1016/j.neuron.2015.07.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Mover, a member of the exquisitely small group of vertebrate-specific presynaptic proteins, has been discovered as an interaction partner of the scaffolding protein Bassoon, yet its function has not been elucidated. We used adeno-associated virus (AAV)-mediated shRNA expression to knock down Mover in the calyx of Held in vivo. Although spontaneous synaptic transmission remained unaffected, we found a strong increase of the evoked EPSC amplitude. The size of the readily releasable pool was unaltered, but short-term depression was accelerated and enhanced, consistent with an increase in release probability after Mover knockdown. This increase in release probability was not caused by alterations in Ca(2+) influx but rather by a higher Ca(2+) sensitivity of the release machinery, as demonstrated by presynaptic Ca(2+) uncaging. We therefore conclude that Mover expression in certain subsets of synapses negatively regulates synaptic release probability, constituting a novel mechanism to tune synaptic transmission.
Collapse
Affiliation(s)
- Christoph Körber
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany.
| | - Heinz Horstmann
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
| | - Varun Venkataramani
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
| | - Frank Herrmannsdörfer
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
| | - Thomas Kremer
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
| | - Michaela Kaiser
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
| | - Darius B Schwenger
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany
| | - Saheeb Ahmed
- European Neuroscience Institute, Grisebachstrasse 5, 37077 Göttingen, Germany
| | - Camin Dean
- European Neuroscience Institute, Grisebachstrasse 5, 37077 Göttingen, Germany
| | - Thomas Dresbach
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany; Department of Anatomy and Embryology, Centre of Anatomy, University of Göttingen, Kreuzbergring 36, 37075 Göttingen, Germany
| | - Thomas Kuner
- Institute of Anatomy and Cell Biology, Heidelberg University, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany.
| |
Collapse
|
37
|
Structural elements that underlie Doc2β function during asynchronous synaptic transmission. Proc Natl Acad Sci U S A 2015. [PMID: 26195798 DOI: 10.1073/pnas.1502288112] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Double C2-like domain-containing proteins alpha and beta (Doc2α and Doc2β) are tandem C2-domain proteins proposed to function as Ca(2+) sensors for asynchronous neurotransmitter release. Here, we systematically analyze each of the negatively charged residues that mediate binding of Ca(2+) to the β isoform. The Ca(2+) ligands in the C2A domain were dispensable for Ca(2+)-dependent translocation to the plasma membrane, with one exception: neutralization of D220 resulted in constitutive translocation. In contrast, three of the five Ca(2+) ligands in the C2B domain are required for translocation. Importantly, translocation was correlated with the ability of the mutants to enhance asynchronous release when overexpressed in neurons. Finally, replacement of specific Ca(2+)/lipid-binding loops of synaptotagmin 1, a Ca(2+) sensor for synchronous release, with corresponding loops from Doc2β, resulted in chimeras that yielded slower kinetics in vitro and slower excitatory postsynaptic current decays in neurons. Together, these data reveal the key determinants of Doc2β that underlie its function during the slow phase of synaptic transmission.
Collapse
|
38
|
Di Giovanni J, Sheng ZH. Regulation of synaptic activity by snapin-mediated endolysosomal transport and sorting. EMBO J 2015; 34:2059-77. [PMID: 26108535 DOI: 10.15252/embj.201591125] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Accepted: 05/29/2015] [Indexed: 11/09/2022] Open
Abstract
Recycling synaptic vesicles (SVs) transit through early endosomal sorting stations, which raises a fundamental question: are SVs sorted toward endolysosomal pathways? Here, we used snapin mutants as tools to assess how endolysosomal sorting and trafficking impact presynaptic activity in wild-type and snapin(-/-) neurons. Snapin acts as a dynein adaptor that mediates the retrograde transport of late endosomes (LEs) and interacts with dysbindin, a subunit of the endosomal sorting complex BLOC-1. Expressing dynein-binding defective snapin mutants induced SV accumulation at presynaptic terminals, mimicking the snapin(-/-) phenotype. Conversely, over-expressing snapin reduced SV pool size by enhancing SV trafficking to the endolysosomal pathway. Using a SV-targeted Ca(2+) sensor, we demonstrate that snapin-dysbindin interaction regulates SV positional priming through BLOC-1/AP-3-dependent sorting. Our study reveals a bipartite regulation of presynaptic activity by endolysosomal trafficking and sorting: LE transport regulates SV pool size, and BLOC-1/AP-3-dependent sorting fine-tunes the Ca(2+) sensitivity of SV release. Therefore, our study provides new mechanistic insights into the maintenance and regulation of SV pool size and synchronized SV fusion through snapin-mediated LE trafficking and endosomal sorting.
Collapse
Affiliation(s)
- Jerome Di Giovanni
- Synaptic Functions Section, The Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| | - Zu-Hang Sheng
- Synaptic Functions Section, The Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
39
|
Abstract
How vesicle calcium sensors interact with calcium channels at synapses affects neurotransmitter release dynamics. In this issue of Neuron, Nakamura et al. (2015) propose that synaptic vesicles are tightly coupled around the perimeter of a voltage-gated calcium channel cluster.
Collapse
Affiliation(s)
- Melissa A Herman
- Neuroscience Research Center, NeuroCure Excellence Cluster, Charité Universitätsmedizin, Charitéplatz 1, 10117 Berlin, Germany
| | - Christian Rosenmund
- Neuroscience Research Center, NeuroCure Excellence Cluster, Charité Universitätsmedizin, Charitéplatz 1, 10117 Berlin, Germany.
| |
Collapse
|
40
|
Synaptic plasticity in the auditory system: a review. Cell Tissue Res 2015; 361:177-213. [PMID: 25896885 DOI: 10.1007/s00441-015-2176-x] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Accepted: 03/18/2015] [Indexed: 01/19/2023]
Abstract
Synaptic transmission via chemical synapses is dynamic, i.e., the strength of postsynaptic responses may change considerably in response to repeated synaptic activation. Synaptic strength is increased during facilitation, augmentation and potentiation, whereas a decrease in synaptic strength is characteristic for depression and attenuation. This review attempts to discuss the literature on short-term and long-term synaptic plasticity in the auditory brainstem of mammals and birds. One hallmark of the auditory system, particularly the inner ear and lower brainstem stations, is information transfer through neurons that fire action potentials at very high frequency, thereby activating synapses >500 times per second. Some auditory synapses display morphological specializations of the presynaptic terminals, e.g., calyceal extensions, whereas other auditory synapses do not. The review focuses on short-term depression and short-term facilitation, i.e., plastic changes with durations in the millisecond range. Other types of short-term synaptic plasticity, e.g., posttetanic potentiation and depolarization-induced suppression of excitation, will be discussed much more briefly. The same holds true for subtypes of long-term plasticity, like prolonged depolarizations and spike-time-dependent plasticity. We also address forms of plasticity in the auditory brainstem that do not comprise synaptic plasticity in a strict sense, namely short-term suppression, paired tone facilitation, short-term adaptation, synaptic adaptation and neural adaptation. Finally, we perform a meta-analysis of 61 studies in which short-term depression (STD) in the auditory system is opposed to short-term depression at non-auditory synapses in order to compare high-frequency neurons with those that fire action potentials at a lower rate. This meta-analysis reveals considerably less STD in most auditory synapses than in non-auditory ones, enabling reliable, failure-free synaptic transmission even at frequencies >100 Hz. Surprisingly, the calyx of Held, arguably the best-investigated synapse in the central nervous system, depresses most robustly. It will be exciting to reveal the molecular mechanisms that set high-fidelity synapses apart from other synapses that function much less reliably.
Collapse
|
41
|
Ca2+ channel to synaptic vesicle distance accounts for the readily releasable pool kinetics at a functionally mature auditory synapse. J Neurosci 2015; 35:2083-100. [PMID: 25653365 DOI: 10.1523/jneurosci.2753-14.2015] [Citation(s) in RCA: 65] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Precise regulation of synaptic vesicle (SV) release at the calyx of Held is critical for auditory processing. At the prehearing calyx of Held, synchronous and asynchronous release is mediated by fast and slow releasing SVs within the readily releasable pool (RRP). However, the posthearing calyx has dramatically different release properties. Whether developmental alterations in RRP properties contribute to the accelerated release time course found in posthearing calyces is not known. To study these questions, we performed paired patch-clamp recordings, deconvolution analysis, and numerical simulations of buffered Ca(2+) diffusion and SV release in postnatal day (P) 16-19 mouse calyces, as their release properties resemble mature calyces of Held. We found the P16-P19 calyx RRP consists of two pools: a fast pool (τ ≤ 0.9 ms) and slow pool (τ ∼4 ms), in which release kinetics and relative composition of the two pools were unaffected by 5 mm EGTA. Simulations of SV release from the RRP revealed that two populations of SVs were necessary to reproduce the experimental release rates: (1) SVs located close (∼5-25 nm) and (2) more distal (25-100 nm) to VGCC clusters. This positional coupling was confirmed by experiments showing 20 mm EGTA preferentially blocked distally coupled SVs. Lowering external [Ca(2+)] to in vivo levels reduced only the fraction SVs released from the fast pool. Therefore, we conclude that a dominant parameter regulating the mature calyx RRP release kinetics is the distance between SVs and VGCC clusters.
Collapse
|
42
|
Tsika E, Nguyen APT, Dusonchet J, Colin P, Schneider BL, Moore DJ. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease. Neurobiol Dis 2015; 77:49-61. [PMID: 25731749 DOI: 10.1016/j.nbd.2015.02.019] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2014] [Revised: 02/17/2015] [Accepted: 02/20/2015] [Indexed: 01/13/2023] Open
Abstract
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause late-onset, autosomal dominant Parkinson's disease (PD). LRRK2 contains functional GTPase and kinase domains. The most common G2019S mutation enhances the kinase activity of LRRK2 in vitro whereas G2019S LRRK2 expression in cultured neurons induces toxicity in a kinase-dependent manner. These observations suggest a potential role for kinase activity in LRRK2-associated PD. We have recently developed a novel rodent model of PD with progressive neurodegeneration induced by the adenoviral-mediated expression of G2019S LRRK2. In the present study, we further characterize this LRRK2 model and determine the contribution of kinase activity to LRRK2-mediated neurodegeneration. Recombinant human adenoviral vectors were employed to deliver human wild-type, G2019S or kinase-inactive G2019S/D1994N LRRK2 to the rat striatum. LRRK2-dependent pathology was assessed in the striatum, a region where LRRK2 protein is normally enriched in the mammalian brain. Human LRRK2 variants are robustly expressed throughout the rat striatum. Expression of G2019S LRRK2 selectively induces the accumulation of neuronal ubiquitin-positive inclusions accompanied by neurite degeneration and the altered distribution of axonal phosphorylated neurofilaments. Importantly, the introduction of a kinase-inactive mutation (G2019S/D1994N) completely ameliorates the pathological effects of G2019S LRRK2 in the striatum supporting a kinase activity-dependent mechanism for this PD-associated mutation. Collectively, our study further elucidates the pathological effects of the G2019S mutation in the mammalian brain and supports the development of kinase inhibitors as a potential therapeutic approach for treating LRRK2-associated PD. This adenoviral rodent model provides an important tool for elucidating the molecular basis of LRRK2-mediated neurodegeneration.
Collapse
Affiliation(s)
- Elpida Tsika
- Laboratory of Molecular Neurodegenerative Research, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
| | - An Phu Tran Nguyen
- Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI 49503, USA
| | - Julien Dusonchet
- Neurodegenerative Studies Laboratory, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
| | - Philippe Colin
- Neurodegenerative Studies Laboratory, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
| | - Bernard L Schneider
- Neurodegenerative Studies Laboratory, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
| | - Darren J Moore
- Laboratory of Molecular Neurodegenerative Research, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
| |
Collapse
|
43
|
Paul MM, Pauli M, Ehmann N, Hallermann S, Sauer M, Kittel RJ, Heckmann M. Bruchpilot and Synaptotagmin collaborate to drive rapid glutamate release and active zone differentiation. Front Cell Neurosci 2015; 9:29. [PMID: 25698934 PMCID: PMC4318344 DOI: 10.3389/fncel.2015.00029] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2014] [Accepted: 01/16/2015] [Indexed: 11/13/2022] Open
Abstract
The active zone (AZ) protein Bruchpilot (Brp) is essential for rapid glutamate release at Drosophila melanogaster neuromuscular junctions (NMJs). Quantal time course and measurements of action potential-waveform suggest that presynaptic fusion mechanisms are altered in brp null mutants (brp(69) ). This could account for their increased evoked excitatory postsynaptic current (EPSC) delay and rise time (by about 1 ms). To test the mechanism of release protraction at brp(69) AZs, we performed knock-down of Synaptotagmin-1 (Syt) via RNAi (syt(KD) ) in wildtype (wt), brp(69) and rab3 null mutants (rab3(rup) ), where Brp is concentrated at a small number of AZs. At wt and rab3(rup) synapses, syt(KD) lowered EPSC amplitude while increasing rise time and delay, consistent with the role of Syt as a release sensor. In contrast, syt(KD) did not alter EPSC amplitude at brp(69) synapses, but shortened delay and rise time. In fact, following syt(KD) , these kinetic properties were strikingly similar in wt and brp(69) , which supports the notion that Syt protracts release at brp(69) synapses. To gain insight into this surprising role of Syt at brp(69) AZs, we analyzed the structural and functional differentiation of synaptic boutons at the NMJ. At 'tonic' type Ib motor neurons, distal boutons contain more AZs, more Brp proteins per AZ and show elevated and accelerated glutamate release compared to proximal boutons. The functional differentiation between proximal and distal boutons is Brp-dependent and reduced after syt(KD) . Notably, syt(KD) boutons are smaller, contain fewer Brp positive AZs and these are of similar number in proximal and distal boutons. In addition, super-resolution imaging via dSTORM revealed that syt(KD) increases the number and alters the spatial distribution of Brp molecules at AZs, while the gradient of Brp proteins per AZ is diminished. In summary, these data demonstrate that normal structural and functional differentiation of Drosophila AZs requires concerted action of Brp and Syt.
Collapse
Affiliation(s)
- Mila M Paul
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| | - Martin Pauli
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| | - Nadine Ehmann
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| | - Stefan Hallermann
- Carl-Ludwig-Institute for Physiology, University of Leipzig Leipzig, Germany
| | - Markus Sauer
- Department of Biotechnology and Biophysics, Julius-Maximilians-University Würzburg Würzburg, Germany
| | - Robert J Kittel
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| | - Manfred Heckmann
- Department of Neurophysiology, Institute of Physiology, Julius-Maximilians-University Würzburg Würzburg, Germany
| |
Collapse
|
44
|
Wang LY, Augustine GJ. Presynaptic nanodomains: a tale of two synapses. Front Cell Neurosci 2015; 8:455. [PMID: 25674049 PMCID: PMC4306312 DOI: 10.3389/fncel.2014.00455] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2014] [Accepted: 12/16/2014] [Indexed: 12/30/2022] Open
Abstract
Here we summarize the evidence from two “giant” presynaptic terminals—the squid giant synapse and the mammalian calyx of Held—supporting the involvement of nanodomain calcium signals in triggering of neurotransmitter release. At the squid synapse, there are three main lines of experimental evidence for nanodomain signaling. First, changing the size of the unitary calcium channel current by altering external calcium concentration causes a non-linear change in transmitter release, while changing the number of open channels by broadening the presynaptic action potential causes a linear change in release. Second, low-affinity calcium indicators, calcium chelators, and uncaging of calcium all suggest that presynaptic calcium concentrations are as high as hundreds of micromolar, which is more compatible with a nanodomain type of calcium signal. Finally, neurotransmitter release is much less affected by the slow calcium chelator, ethylene glycol tetraacetic acid (EGTA), in comparison to the rapid chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA). Similarly, as the calyx of Held synapse matures, EGTA becomes less effective in attenuating transmitter release while the number of calcium channels required to trigger a single fusion event declines. This suggests a developmental transformation of microdomain to nanodomain coupling between calcium channels and transmitter release. Calcium imaging and uncaging experiments, in combination with simulations of calcium diffusion, indicate the peak calcium concentration seen by presynaptic calcium sensors reaches at least tens of micromolar at the calyx of Held. Taken together, data from these provide a compelling argument that nanodomain calcium signaling gates very rapid transmitter release.
Collapse
Affiliation(s)
- Lu-Yang Wang
- Program in Neurosciences and Mental Health, SickKids Research Institute Toronto, Canada ; Department of Physiology, University of Toronto Toronto, Canada
| | - George J Augustine
- Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore ; Institute of Molecular and Cell Biology Singapore, Singapore ; Center for Functional Connectomics, Korea Institute of Science and Technology Seoul, South Korea ; Marine Biological Laboratory Woods Hole, MA, USA
| |
Collapse
|
45
|
Nakamura Y, Harada H, Kamasawa N, Matsui K, Rothman JS, Shigemoto R, Silver RA, DiGregorio DA, Takahashi T. Nanoscale distribution of presynaptic Ca(2+) channels and its impact on vesicular release during development. Neuron 2014; 85:145-158. [PMID: 25533484 PMCID: PMC4305191 DOI: 10.1016/j.neuron.2014.11.019] [Citation(s) in RCA: 163] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/14/2014] [Indexed: 01/05/2023]
Abstract
Synaptic efficacy and precision are influenced by the coupling of voltage-gated Ca2+ channels (VGCCs) to vesicles. But because the topography of VGCCs and their proximity to vesicles is unknown, a quantitative understanding of the determinants of vesicular release at nanometer scale is lacking. To investigate this, we combined freeze-fracture replica immunogold labeling of Cav2.1 channels, local [Ca2+] imaging, and patch pipette perfusion of EGTA at the calyx of Held. Between postnatal day 7 and 21, VGCCs formed variable sized clusters and vesicular release became less sensitive to EGTA, whereas fixed Ca2+ buffer properties remained constant. Experimentally constrained reaction-diffusion simulations suggest that Ca2+ sensors for vesicular release are located at the perimeter of VGCC clusters (<30 nm) and predict that VGCC number per cluster determines vesicular release probability without altering release time course. This “perimeter release model” provides a unifying framework accounting for developmental changes in both synaptic efficacy and time course. Ca2+ channels form clusters with highly variable numbers of channels EGTA sensitivity suggests that synaptic vesicles are tightly coupled to clusters Ca2+ channel number per cluster alters synaptic efficacy, but not precision A perimeter model accounts for synaptic efficacy and precision during development
Collapse
Affiliation(s)
- Yukihiro Nakamura
- Laboratory of Molecular Synaptic Function, Graduate School of Brain Science, Doshisha University, Kyoto 610-0394, Japan; Cellular & Molecular Synaptic Function Unit, Okinawa Institute of Science and Technology (OIST) Graduate University, Okinawa 904-0495, Japan; Laboratory of Dynamic Neuronal Imaging, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France; CNRS UMR 3571, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
| | - Harumi Harada
- Division of Cerebral Structure, Department of Cerebral Research, National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan; Institute of Science and Technology Austria, A-3400 Klosterneuburg, Austria
| | - Naomi Kamasawa
- Division of Cerebral Structure, Department of Cerebral Research, National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan
| | - Ko Matsui
- Division of Cerebral Structure, Department of Cerebral Research, National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan
| | - Jason S Rothman
- Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street London WC1E 6BT, UK
| | - Ryuichi Shigemoto
- Division of Cerebral Structure, Department of Cerebral Research, National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan; Institute of Science and Technology Austria, A-3400 Klosterneuburg, Austria
| | - R Angus Silver
- Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street London WC1E 6BT, UK
| | - David A DiGregorio
- Laboratory of Dynamic Neuronal Imaging, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France; CNRS UMR 3571, 25 rue du Dr Roux, 75724 Paris Cedex 15, France.
| | - Tomoyuki Takahashi
- Laboratory of Molecular Synaptic Function, Graduate School of Brain Science, Doshisha University, Kyoto 610-0394, Japan; Cellular & Molecular Synaptic Function Unit, Okinawa Institute of Science and Technology (OIST) Graduate University, Okinawa 904-0495, Japan.
| |
Collapse
|
46
|
Ma J, Kelly L, Ingram J, Price TJ, Meriney SD, Dittrich M. New insights into short-term synaptic facilitation at the frog neuromuscular junction. J Neurophysiol 2014; 113:71-87. [PMID: 25210157 DOI: 10.1152/jn.00198.2014] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Short-term synaptic facilitation occurs during high-frequency stimulation, is known to be dependent on presynaptic calcium ions, and persists for tens of milliseconds after a presynaptic action potential. We have used the frog neuromuscular junction as a model synapse for both experimental and computer simulation studies aimed at testing various mechanistic hypotheses proposed to underlie short-term synaptic facilitation. Building off our recently reported excess-calcium-binding-site model of synaptic vesicle release at the frog neuromuscular junction (Dittrich M, Pattillo JM, King JD, Cho S, Stiles JR, Meriney SD. Biophys J 104: 2751-2763, 2013), we have investigated several mechanisms of short-term facilitation at the frog neuromuscular junction. Our studies place constraints on previously proposed facilitation mechanisms and conclude that the presence of a second class of calcium sensor proteins distinct from synaptotagmin can explain known properties of facilitation observed at the frog neuromuscular junction. We were further able to identify a novel facilitation mechanism, which relied on the persistent binding of calcium-bound synaptotagmin molecules to lipids of the presynaptic membrane. In a real physiological context, both mechanisms identified in our study (and perhaps others) may act simultaneously to cause the experimentally observed facilitation. In summary, using a combination of computer simulations and physiological recordings, we have developed a stochastic computer model of synaptic transmission at the frog neuromuscular junction, which sheds light on the facilitation mechanisms in this model synapse.
Collapse
Affiliation(s)
- Jun Ma
- Biomedical Applications Group, Pittsburgh Supercomputing Center, Carnegie Mellon University, Pittsburgh, Pennsylvania; Joint Carnegie Mellon-University of Pittsburgh PhD Program in Computational Biology, School of Computer Science, Carnegie Mellon University, Pittsburgh, Pennsylvania
| | - Lauren Kelly
- Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania; and
| | - Justin Ingram
- Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania; and
| | - Thomas J Price
- Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania; and
| | - Stephen D Meriney
- Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania; and
| | - Markus Dittrich
- Biomedical Applications Group, Pittsburgh Supercomputing Center, Carnegie Mellon University, Pittsburgh, Pennsylvania; Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania
| |
Collapse
|
47
|
Gene delivery in mouse auditory brainstem and hindbrain using in utero electroporation. Mol Brain 2014; 7:51. [PMID: 25063346 PMCID: PMC4222606 DOI: 10.1186/s13041-014-0051-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2014] [Accepted: 07/14/2014] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Manipulation of gene expression via recombinant viral vectors and creation of transgenic knock-out/in animals has revolutionized our understanding of genes that play critical roles during neuronal development and pathophysiology of neurological disorders. Recently, target-specific genetic manipulations are made possible to perform in combination with specific Cre-lines, albeit costly, labor-intensive and time consuming. Thus, alternative methods of gene manipulations to address important biological questions are highly desirable. In this study, we utilized in utero electroporation technique which involves efficient delivery of hindbrain-specific enhancer/promoter construct, Krox20 into the third ventricle of live mouse embryo to investigate green fluorescent protein (GFP) expression pattern in mouse auditory brainstem and other hindbrain neurons. RESULTS We created a GFP/DNA construct containing a Krox20 B enhancer and β-globin promoter to drive GFP expression in the hindbrain via injection into the third ventricle of E12 to E13.5 mice. Electrical currents were applied directly to the embryonic hindbrain to allow DNA uptake into the cell. Confocal images were then acquired from fixed brain slices to analyze GFP expression in mouse whole brain at different postnatal stages (P6-P21). By using a cell-type specific enhancer as well as region specific injection and electroporation, robust GFP expression in the cerebellum and auditory brainstem but not in the forebrain was observed. GFP expression in calyx of Held terminals was more robust in <P15 compared to >P15 mice. In contrast, GFP expression in MNTB neurons was more prevalent in >P15 compared to <P15. In regards to the relative expression of GFP versus the synaptic marker Vglut1, percentage fluorescence GFP intensity in the calyx was higher in P11 to P15 than P6 to P10 and P16 to P21 groups. CONCLUSIONS Taken together, this technique would potentially allow hindbrain-specific genetic manipulations such as knock-down, knock-in and rescue experiments to unravel critical molecular substrates underpinning functional and morphological remodeling of synapses as well as understanding the pathophysiology of certain neurological disorders targeting not only the auditory brainstem but also other parts of hindbrain, most notably the cerebellum.
Collapse
|
48
|
Meriney SD, Umbach JA, Gundersen CB. Fast, Ca2+-dependent exocytosis at nerve terminals: shortcomings of SNARE-based models. Prog Neurobiol 2014; 121:55-90. [PMID: 25042638 DOI: 10.1016/j.pneurobio.2014.07.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Revised: 04/14/2014] [Accepted: 07/03/2014] [Indexed: 11/30/2022]
Abstract
Investigations over the last two decades have made major inroads in clarifying the cellular and molecular events that underlie the fast, synchronous release of neurotransmitter at nerve endings. Thus, appreciable progress has been made in establishing the structural features and biophysical properties of the calcium (Ca2+) channels that mediate the entry into nerve endings of the Ca2+ ions that trigger neurotransmitter release. It is now clear that presynaptic Ca2+ channels are regulated at many levels and the interplay of these regulatory mechanisms is just beginning to be understood. At the same time, many lines of research have converged on the conclusion that members of the synaptotagmin family serve as the primary Ca2+ sensors for the action potential-dependent release of neurotransmitter. This identification of synaptotagmins as the proteins which bind Ca2+ and initiate the exocytotic fusion of synaptic vesicles with the plasma membrane has spurred widespread efforts to reveal molecular details of synaptotagmin's action. Currently, most models propose that synaptotagmin interfaces directly or indirectly with SNARE (soluble, N-ethylmaleimide sensitive factor attachment receptors) proteins to trigger membrane fusion. However, in spite of intensive efforts, the field has not achieved consensus on the mechanism by which synaptotagmins act. Concurrently, the precise sequence of steps underlying SNARE-dependent membrane fusion remains controversial. This review considers the pros and cons of the different models of SNARE-mediated membrane fusion and concludes by discussing a novel proposal in which synaptotagmins might directly elicit membrane fusion without the intervention of SNARE proteins in this final fusion step.
Collapse
Affiliation(s)
- Stephen D Meriney
- Department of Neuroscience, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA
| | - Joy A Umbach
- Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA
| | - Cameron B Gundersen
- Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
| |
Collapse
|
49
|
Fà M, Staniszewski A, Saeed F, Francis YI, Arancio O. Dynamin 1 is required for memory formation. PLoS One 2014; 9:e91954. [PMID: 24643165 PMCID: PMC3958425 DOI: 10.1371/journal.pone.0091954] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2013] [Accepted: 02/16/2014] [Indexed: 02/07/2023] Open
Abstract
Dynamin 1–3 isoforms are known to be involved in endocytotic processes occurring during synaptic transmission. No data has directly linked dynamins yet with normal animal behavior. Here we show that dynamin pharmacologic inhibition markedly impairs hippocampal-dependent associative memory. Memory loss was associated with changes in synaptic function occurring during repetitive stimulation that is thought to be linked with memory induction. Synaptic fatigue was accentuated by dynamin inhibition. Moreover, dynamin inhibition markedly reduced long-term potentiation, post-tetanic potentiation, and neurotransmitter released during repetitive stimulation. Most importantly, the effect of dynamin inhibition onto memory and synaptic plasticity was due to a specific involvement of the dynamin 1 isoform, as demonstrated through a genetic approach with siRNA against this isoform to temporally block it. Taken together, these findings identify dynamin 1 as a key protein for modulation of memory and release evoked by repetitive activity.
Collapse
Affiliation(s)
- Mauro Fà
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America
| | - Agnieszka Staniszewski
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America
| | - Faisal Saeed
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America
| | - Yitshak I. Francis
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America
| | - Ottavio Arancio
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, United States of America
- * E-mail:
| |
Collapse
|
50
|
Genc O, Kochubey O, Toonen RF, Verhage M, Schneggenburger R. Munc18-1 is a dynamically regulated PKC target during short-term enhancement of transmitter release. eLife 2014; 3:e01715. [PMID: 24520164 PMCID: PMC3919271 DOI: 10.7554/elife.01715] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Transmitter release at synapses is regulated by preceding neuronal activity, which can give rise to short-term enhancement of release like post-tetanic potentiation (PTP). Diacylglycerol (DAG) and Protein-kinase C (PKC) signaling in the nerve terminal have been widely implicated in the short-term modulation of transmitter release, but the target protein of PKC phosphorylation during short-term enhancement has remained unknown. Here, we use a gene-replacement strategy at the calyx of Held, a large CNS model synapse that expresses robust PTP, to study the molecular mechanisms of PTP. We find that two PKC phosphorylation sites of Munc18-1 are critically important for PTP, which identifies the presynaptic target protein for the action of PKC during PTP. Pharmacological experiments show that a phosphatase normally limits the duration of PTP, and that PTP is initiated by the action of a ‘conventional’ PKC isoform. Thus, a dynamic PKC phosphorylation/de-phosphorylation cycle of Munc18-1 drives short-term enhancement of transmitter release during PTP. DOI:http://dx.doi.org/10.7554/eLife.01715.001 Brain function depends on the rapid transfer of information from one brain cell to the next at junctions known as synapses. Small packages called vesicles play an important role in this process. The arrival of an electrical action potential at the nerve terminal of the first cell causes some vesicles in the cell to fuse with the cell membrane, and this leads to the neurotransmitters inside the vesicles being released into the synapse. The neurotransmitters then bind to receptors on the second cell, which leads to an electrical signal in the second cell. A protein called Munc18-1 has a central role in the fusion of the vesicle at the cell membrane. The strength of a synapse—that is, how easily the first brain cell can impact the electrical behaviour of the second—can change, and this ‘synaptic plasticity’ is thought to underlie learning and memory. Long-term changes in synaptic strength require additional receptors to be inserted into the membrane of the second cell. However, synapses can also be temporarily strengthened: the arrival of a burst of action potentials—a tetanus—causes some synapses to increase the amount of neurotransmitter they release in response to any subsequent, single, action potential. This temporary increase in synaptic strength, which is known as post-tetanic potentiation, requires an enzyme called protein kinase C; the role of this enzyme is to phosphorylate specific target proteins (i.e., to add phosphate groups to them). Now, Genç et al. have genetically modified a mouse synapse in vivo and shown that protein kinase C brings about post-tetanic potentiation by phosphorylating Munc18-1. Furthermore, pharmacological experiments show that proteins called phosphatases, which de-phosphorylate proteins, normally terminate the post-tetanic potentiation after about one minute. Taken together, the study identifies a target protein which is phosphorylated by protein kinase C during post-tetanic potentiation. The study also suggests that in addition to its fundamental role in vesicle fusion, the phosphorylation state of Munc18-1 can change the probability of vesicle fusion in a more subtle way, thereby contributing to synaptic plasticity. DOI:http://dx.doi.org/10.7554/eLife.01715.002
Collapse
Affiliation(s)
- Ozgür Genc
- Laboratory of Synaptic Mechanisms, Brain Mind Institute, School of Life Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | | | | | | | | |
Collapse
|